Works matching IS 09024441 AND DT 2022 AND VI 108 AND IP 6

Results: 12

Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 518, doi. 10.1111/ejh.13763
By:
- Kennedy, Megan;
- O' Mahony, Brian;
- Roche, Sheila;
- McGowan, Mark;
- Singleton, Evelyn;
- Ryan, Kevin;
- O' Connell, Niamh M.;
- Pipe, Steven W.;
- Lavin, Michelle;
- O' Donnell, James S.;
- Turecek, Peter L.;
- Gormley, John
Publication type:
Article
Persistent opioid use in patients with multiple myeloma post‐ASCT.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 503, doi. 10.1111/ejh.13759
By:
- Danish, Matthew L.;
- Shah, Mansi R.;
- Lin, Yong;
- Ho, Joseph K.;
- Copeland, Tabitha M.;
- Cooper, Dennis L.
Publication type:
Article
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunity.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 493, doi. 10.1111/ejh.13758
By:
- Heaney, Jennifer L. J.;
- Faustini, Sian;
- Evans, Lili;
- Rapson, Alec;
- Collman, Emily;
- Emery, Annabelle;
- Campbell, John P.;
- Moore, Sally;
- Goodall, Margaret;
- Afzal, Zaheer;
- Chapple, Iain L.;
- Pratt, Guy;
- Drayson, Mark T.
Publication type:
Article
Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 486, doi. 10.1111/ejh.13757
By:
- Langseth, Øystein O.;
- Myklebust, Tor Å.;
- Johannesen, Tom B.;
- Hjertner, Øyvind;
- Waage, Anders
Publication type:
Article
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 532, doi. 10.1111/ejh.13760
By:
- Pérez‐Persona, Ernesto;
- Oiartzabal‐Ormategui, Itziar;
- Herraez, Susana;
- Menchaca, Carmen;
- Cuevas‐Palomares, Laida;
- Santamaría‐López, Ana;
- Díez‐Angulo, Rosana;
- Robles‐Castro, Diego;
- de Miguel‐Sánchez, Carlos;
- Gabilondo‐Jalón, Miren;
- Pisón‐Herrero, Carlos;
- Unamunzaga‐Cilaurren, Ariane;
- Vega González‐Viñaspre, Ana;
- Salcedo‐Cuesta, Laura;
- Mendizabal‐Abad, Arantza;
- Guinea de Castro, José María
Publication type:
Article
Systematic review of hematuria and acute renal failure with tranexamic acid.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 510, doi. 10.1111/ejh.13762
By:
- Lee, Stephanie G.;
- Fralick, John;
- Wallis, Christopher J. D.;
- Boctor, Monica;
- Sholzberg, Michelle;
- Fralick, Michael
Publication type:
Article
Intracranial haemorrhage in AML patients.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 536, doi. 10.1111/ejh.13761
By:
- Murphy, Philip;
- Glavey, Siobhan;
- Quinn, John
Publication type:
Article
Antibody titers after SARS‐CoV‐2 mRNA vaccination in patients with aplastic anemia—A single‐center study.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 528, doi. 10.1111/ejh.13756
By:
- Walter, Jeanette;
- Kricheldorf, Kim;
- Isfort, Susanne;
- Brümmendorf, Tim H.;
- Panse, Jens;
- Beier, Fabian
Publication type:
Article
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 469, doi. 10.1111/ejh.13755
By:
- Vu, Martin;
- Degeling, Koen;
- Thompson, Ella R.;
- Blombery, Piers;
- Westerman, David;
- IJzerman, Maarten J.
Publication type:
Article
Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 460, doi. 10.1111/ejh.13754
By:
- Keegan, Anastazia;
- Dennington, Peta M.;
- Dhondy, Nina;
- Mulligan, Stephen P.
Publication type:
Article
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 449, doi. 10.1111/ejh.13753
By:
- Papayannidis, Cristina;
- Nanni, Jacopo;
- Cristiano, Gianluca;
- Marconi, Giovanni;
- Sartor, Chiara;
- Parisi, Sarah;
- Zannoni, Letizia;
- Saed, Rashed;
- Ottaviani, Emanuela;
- Bandini, Lorenza;
- Testoni, Nicoletta;
- Baldazzi, Carmen;
- Solli, Vincenza;
- Ricci, Paolo;
- Di Giovanni Bezzi, Chiara;
- Abd‐alatif, Rania;
- Stanzani, Marta;
- Paolini, Stefania;
- Cavo, Michele;
- Curti, Antonio
Publication type:
Article
Issue Information.
Published in:
European Journal of Haematology, 2022, v. 108, n. 6, p. 447, doi. 10.1111/ejh.13656
Publication type:
Article